Fresenius Medical Care AG KGaA Long Term Debt 2010-2022 | FMS

Fresenius Medical Care AG KGaA long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
  • Fresenius Medical Care AG KGaA long term debt for the quarter ending December 31, 2022 was $7.555B, a 3.93% decline year-over-year.
  • Fresenius Medical Care AG KGaA long term debt for 2022 was $7.555B, a 3.93% decline from 2021.
  • Fresenius Medical Care AG KGaA long term debt for 2021 was $7.864B, a 1.24% increase from 2020.
  • Fresenius Medical Care AG KGaA long term debt for 2020 was $7.768B, a 7.39% increase from 2019.
Fresenius Medical Care AG KGaA Annual Long Term Debt
(Millions of US $)
2022 $7,555
2021 $7,864
2020 $7,768
2019 $7,233
2018 $5,959
2017 $6,550
2016 $7,203
2015 $7,853
2014 $9,014
2013 $7,747
2012 $7,842
2011 $5,495
2010 $4,310
2009 $4,428
Fresenius Medical Care AG KGaA Quarterly Long Term Debt
(Millions of US $)
2022-12-31 $7,555
2022-09-30 $8,127
2022-06-30 $7,730
2022-03-31 $8,362
2021-12-31 $7,864
2021-09-30 $7,749
2021-06-30 $7,831
2021-03-31 $7,614
2020-12-31 $7,768
2020-09-30 $8,159
2020-06-30 $6,908
2020-03-31 $6,402
2019-12-31 $7,233
2019-09-30 $6,767
2019-06-30 $4,283
2019-03-31 $6,453
2018-12-31 $5,959
2018-09-30 $5,861
2018-06-30 $6,547
2018-03-31 $7,126
2017-12-31 $6,550
2017-09-30 $6,855
2017-06-30 $7,027
2017-03-31 $7,182
2016-12-31 $7,203
2016-09-30 $7,174
2016-06-30 $7,702
2016-03-31 $7,847
2015-12-31 $7,853
2015-09-30 $8,351
2015-06-30 $8,798
2015-03-31 $8,602
2014-12-31 $9,014
2014-09-30 $7,713
2014-06-30 $8,444
2014-03-31 $8,016
2013-12-31 $7,747
2013-09-30 $7,772
2013-06-30 $7,657
2013-03-31 $7,361
2012-12-31 $7,842
2012-09-30 $7,734
2012-06-30 $5,543
2012-03-31 $5,583
2011-12-31 $5,495
2011-09-30 $5,487
2011-06-30 $5,960
2011-03-31
2010-12-31 $4,310
2010-09-30 $4,311
2010-06-30 $2,949
2010-03-31 $3,029
2009-12-31 $4,428
2009-09-30 $4,561
2009-06-30 $4,421
2009-03-31 $3,961
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.408B $20.441B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.206B 23.69
Edwards Lifesciences (EW) United States $49.143B 32.69
Alcon (ALC) Switzerland $32.311B 29.57
STERIS (STE) Ireland $17.996B 22.80
Teleflex (TFX) United States $11.141B 18.17
Penumbra (PEN) United States $10.162B 1565.71
Globus Medical (GMED) United States $5.255B 25.31
Integer Holdings (ITGR) United States $2.448B 18.98
Glaukos (GKOS) United States $2.324B 0.00
Paragon 28 (FNA) United States $1.527B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.330B 17.30
Nevro (NVRO) United States $1.089B 0.00
Artivion (AORT) United States $0.488B 240.60